Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN133,7133,762,60
Msft1,11
Nokia7,3787,3962,85
IBM2,06
Mercedes-Benz Group AG52,6352,71-0,32
PFE-0,81
03.04.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 03.04.2026 2:00:00
Canopy Grow Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
1,00 2,63 0,03 6 451 834
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiCanopy Growth Corp
TickerWEED
Kmenové akcie:Ordinary Shares
Kmenové akcie:Ordinary Shares
RICWEED.TO
ISIN-
Poslední známé roční výsledky31.03.2025
Poslední známé čtvrtletní výsledky31.12.2025
Počet zaměstnanců k 31.03.2025 960
Akcie v oběhu k 17.03.2026 377 862 634
MěnaCAD
Kontaktní informace
Ulice1 Hershey Dr
MěstoSMITHS FALLS
PSČK7A 0A8
ZeměCanada
Kontatní osoba 
Funkce kontaktní osoby 
Telefon16 135 999 600
Fax16135990018

Business Summary: Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany.
Financial Summary: BRIEF: For the nine months ended 31 December 2025, Canopy Growth Corp revenues increased 5% to C$213.4M. Net loss before extraordinary items decreased 72% to C$105.8M. Revenues reflect Canada segment increase of 21% to C$139.4M. Lower net loss reflects Interest expense decrease of 56% to C$25.9M (expense), Selling, General and administration - Ba decrease of 21% to C$89M (expense).
Odvětvová klasifikace
TRBC2012Alternative Medicine
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSOther Financial Vehicles
NAICSTobacco Product and Electronic Cigarette Merchant Wholesalers
NAICS2007Medicinal & Botanical Mfg
NAICS1997Medicinal and Botanical Manufacturing
SICInvestment Offices, Nec
SICMedicinals And Botanicals
SICTobacco And Tobacco Products



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, DirectorLuc Mongeau5906.01.202506.01.2025
Chief Financial OfficerThomas Stewart4316.03.2026
Chief Operating OfficerMichael Perron-16.03.202616.03.2026
Senior Vice President - Medical SalesAndrew Bevan-16.03.202616.03.2026
Senior Vice President - Human ResourcesChrissy McHardy-16.03.202616.03.2026
Managing Director of Storz & BickelDavid Manner-01.04.202601.04.2026
Chief Business Development & Corporate Affairs OfficerChristelle Gedeon4416.03.202601.08.2022